Back to results
US 2020/0023051 A1Published application
Immunogenic compositions
AssigneeGlaxosmithkline Biologicals SA
InventorsBeatrice RICCHETTI, Isabel DELANY
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of native outer membrane vesicles (nOMVs), particularly nOMVs having increased levels of lipoproteins on their surface and use of same in immunogenic compositions.
Claims18
A hyper-blebbing Gram-negative bacterium which over-expresses, constitutively expresses or inducibly expresses a flippase.
Dependencies are inferred from the claim text.